Treace Medical Concepts stockholders elect three Class I directors, ratify Grant Thornton as auditor

TREACE MEDICAL CONCEPTS, INC.

Lance A. Berry, Elizabeth Hanna, and Jane E. Kiernan elected to Class I board for term expiring 2025; Berry received 49.8M for, Hanna 39.9M for, Kiernan 49.8M for.
Grant Thornton LLP ratified as independent auditor for fiscal year ending Dec 31, 2023: 56,651,839 for, 5,348 against, 29,343 abstain.
Broker non-votes: 4,279,391 on director elections; none on auditor ratification.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

TREACE MEDICAL CONCEPTS, INC. shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2023-05-23 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2023-05-23

Exact text from the filing

The stockholders ratified, by the votes indicated below, the appointment of Grant Thornton LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023.

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

TREACE MEDICAL CONCEPTS, INC. shareholders approved Election of Class I Directors at the 2023-05-23 meeting.

Proposal: director election
Outcome: passed
Meeting: 2023-05-23

Exact text from the filing

The stockholders elected, by the votes indicated below, the following nominees to the Company’s Board of Directors to serve as Class I directors for a three-year term of office expiring at the 2025 annual meeting of the stockholders or until their respective successors have been duly elected and qualified:

View on SEC.gov

Browse all shareholder votes →

TREACE MEDICAL CONCEPTS, INC. filing history →

Source: SEC EDGAR

accession 0000950170-23-024559

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.